Showing results (71-80 of 831) with videos related to
Sort By:
Pageof 84
Seminars in Oncology|February 1, 2017
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher AlbitarClinical Lymphoma, Myeloma & Leukemia|June 25, 2013
Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approvalHagop M Kantarjian, Susan O'Brien, Jorge CortesCurrent Molecular Medicine|November 25, 2005
Monoclonal antibodies in the treatment of leukemiaSusan O'Brien, Maher Albitar, Francis J GilesJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Investigational immunotherapeutics for B-cell malignanciesAlfonso Quintás-Cardama, William Wierda, Susan O'BrienExpert Review of Hematology|May 2, 2024
Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizonNghia Pham, Catherine C Coombs, Susan O'BrienLancet (London, England)|July 28, 2024
Chronic lymphocytic leukaemiaNitin Jain, William G Wierda, Susan O'BrienSeminars in Oncology|February 14, 2002
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher AlbitarBest Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J KeatingExpert Review of Hematology|July 17, 2020
Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategiesTsering Gyalpo Lama, Daniel Kyung, Susan O'BrienLeukemia & Lymphoma|April 18, 2009
N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemiaNeil E Kay, Tait D Shanafelt, Timothy G Call, et al.Pageof 84